Patent Settlement Aids University of Rochester
Merck & Co. and GlaxoSmithKline announced that they have settled their disputes over patents in connection with vaccines that could prevent cervical cancer. This should speed up the development of the vaccines that will protect against human papillomavirus, an infection that causes most cervical cancer.
Research done a decade ago by three UR scientists plays a key role in the vaccine technology.
While no financial details were disclosed, Marjorie Hunter, director of the UR medical center's Office of Technology Transfer, said royalty payments to the university would be "substantial."